TCT-243 Long-term residual risk according to optimal medical treatment in acute myocardial infarction treated with percutaneous coronary
Byung‐Hee Hwang(The Catholic University of Korea Seoul St. Mary's Hospital), Ki‐Bae Seung, Kiyuk Chang(St. Mary's Hospital), Young Soo Lee(Government of the Republic of Korea), Ha-Wook Park(Chonnam National University Hospital), Hun‐Jun Park(Soonchunhyang University), Sungmin Lim(University of Illinois Urbana-Champaign), Myung Ho Jeong(Veterans Health Service Medical Center), Yoon Seok Koh(The Catholic University of Korea Uijeongbu St. Mary's Hospital), Wook Sung Chung(The Catholic University of Korea Seoul St. Mary's Hospital), Hee-Yeol Kim(The Catholic University of Korea Bucheon St. Mary's Hospital), Pum Joon Kim(St. Paul's Hospital), Eun Ho Choo(The Catholic University of Korea Seoul St. Mary's Hospital)
Cited by 1
Related Papers
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound
|Journal of the American College of Cardiology|2002|1k
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
|New England Journal of Medicine|2010|510
Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
|New England Journal of Medicine|2008|493